Ozempic (semaglutide) and Mounjaro (tirzepatide) are injectable type 2 diabetes medications prescribed to lower blood sugar, but they have different mechanisms of action. These medications have also garnered attention for their potential weight loss effects.

Use of the diabetes medication Ozempic and other GLP-1 drugs for weight loss is rising. Discover the research, how they work, who should try these, and more.

Ozempic and other GLP-1 agonists can aid in blood sugar and weight management and function as treatments for for people with diabetes, obesity and some other health conditions.

A new outpatient “gut reset” procedure could help people keep weight off after stopping drugs like Ozempic and semaglutide, tackling one of the biggest frustrations with these treatments. Credit: Shutterstock A quick “gut reset” may help keep weight off after Ozempic.

Ivim Health reports on the effectiveness of GLP-1 pills vs. Ozempic, emphasizing personalized care for obesity management.

Phase 3 trial data show a synthetic semaglutide injection provides glycemic control comparable to Ozempic in patients with type 2 diabetes.

The entry of Dr Reddy's generic is triggering a price battle among pharmaceutical companies worldwide.

Ozempic (semaglutide) is Food and Drug Administration (FDA)-approved for type 2 diabetes. It may be prescribed off-label to help manage weight and metabolic concerns in people with polycystic ovary syndrome (PCOS),

When large clinical trials of semaglutide, the compound behind Ozempic and Wegovy, began reporting results, the headline numbers were about pounds lost and blood sugar controlled. But buried in the lab work was a quieter finding that has since moved to the center of a growing scientific debate: the drug appears to reduce chronic inflammation